MGI’s Innovative Technologies Is Enabling Sequencing of First Plant Species in The African BioGenome Project

MGI, a company committed to building core tools and technology to lead life science, is delighted to support The African BioGenome Project (AfricaBP), launched in 2021, in sequencing of the project’s first plant species based on MGI’s DNBSEQ-G400* versatile benchtop sequencer and single-tube long fragment read (stLFR) technology.

Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer

SAN FRANCISCO — A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients with locally advanced or metastatic penile cancer, according

February 17, 2025

Photon-counting CT protocol shows promise for lung imaging

New CT technology allows for a comprehensive, simultaneous evaluation of lung structure and function, something not possible with standard CT, according to a study published

July 11, 2023

TheracosBio to introduce BRENZAVVY in sub-Saharan Africa

Results from Phase III clinical trials have demonstrated that BRENZAVVY significantly lowers haemoglobin A1c and fasting blood sugar levels over 24 weeks. Credit: Dragana Gordic/Shutterstock.

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.